Market revenue in 2023 | USD 21.4 million |
Market revenue in 2030 | USD 41.0 million |
Growth rate | 9.8% (CAGR from 2023 to 2030) |
Largest segment | Sequencing by synthesis |
Fastest growing segment | Sequencing by synthesis |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Sequencing by synthesis, Sequencing by ligation, Sanger sequencing |
Key market players worldwide | Microbiome Insights Inc., BaseClear, Clinical Microbiomics, Mérieux NutriSciences Corporation, Mr Dna, Metabiomics, Rancho BioSciences, Second Genome, Zymo Research, uBiome |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microbiome sequencing services market will help companies and investors design strategic landscapes.
Sequencing by synthesis was the largest segment with a revenue share of 59.35% in 2023. Horizon Databook has segmented the Sweden microbiome sequencing services market based on sequencing by synthesis, sequencing by ligation, sanger sequencing covering the revenue growth of each sub-segment from 2018 to 2030.
In Sweden, increased usage of sequencing in clinical practice for proper diagnosis and treatment is driving the market. For instance, in 2021, around 2,000 samples were analyzed with whole-exome sequencing and 5,000 samples with whole-genome sequencing in a clinical routine in Sweden.
In addition, the collaboration between SciLifeLab Clinical Genomics platform and Genomic Medicine Sweden (GMS) to develop precision diagnostics has enabled the use of whole-genome sequencing for rare diseases in hospitals.
Increasing adoption of sequencing techniques in hospitals and laboratories has further boosted the demand for sequencing technologies in the country. In June 2022 CosmosID, a leading microbial genomics company, inked a partnership with Locus Biosciences to offer long-term clinical trial support.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden microbiome sequencing services market , including forecasts for subscribers. This country databook contains high-level insights into Sweden microbiome sequencing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account